From Legacy Roots to Global Growth
We are MTL Cannabis Corp.
A leader in premium craft cannabis, medical cannabis distribution, and exporter to international medical cannabis markets.
From our legacy market roots to our position as a publicly traded company, we grow with purpose, precision, and passion.
THE NEWS
Latest & Greatest

PICKERING, ON, le 28 nov. 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) (OTCQX: MTLNF) (« MTL » ou la « Société ») a le plaisir d'annoncer le dépôt de ses états financiers pour les périodes de trois mois et de six mois se terminant les 30 septembre 2025 et 2024. Vous trouverez tous les détails dans le profil SEDAR+ de la Société à www.sedarplus.ca . Faits saillants financiers consolidés du deuxième trimestre de 2025 : La Société a réalisé un revenu de 25 365 570 $ pendant le deuxième trimestre de l'exercice 2026 par rapport à 26 434 502 $ lors du trimestre correspondant de l'exercice financier précédent. La Société a réalisé un revenu net de 20 613 664 $ pendant le deuxième trimestre de l'exercice 2026 par rapport à 20 869 898 $ lors du trimestre correspondant de l'exercice financier précédent. La Société a réalisé des marges brutes avant ajustements de la juste valeur de 50 % pendant le deuxième trimestre de l'exercice 2026, soit une augmentation de 7 % par rapport au trimestre précédent, et une baisse de 4 % par rapport à 54 % au même trimestre de l'exercice financier précédent. La Société continue de réaliser un BAIIA ajusté positif de 2 223 919 $ pendant le deuxième trimestre de l'exercice 2026. (1) Voir la section « Mesures financières non conformes aux IFRS » ci-dessous pour le rapprochement du BAIIA et du BAIIA ajusté.

PICKERING, ON, Nov. 28, 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) (OTCQX: MTLNF) ("MTL" or the "Company") is pleased to report it has filed its financial statements as at and for the three-month and six-month periods ending September 30, 2025, and 2024. Complete details may be found on the Company's SEDAR+ profile at www.sedarplus.ca . Second Quarter 2025 Consolidated Financial Highlights: The Company generated revenue of $25,365,570 during the second quarter of fiscal 2026, compared to $26,434,502 in the same quarter of last fiscal year. The Company generated net revenue of $20,613,664 during the second quarter of fiscal 2026, compared to $20,869,898 in the same quarter of last fiscal year. The Company generated gross margins before fair value adjustments of 50% during the second quarter of fiscal 2026, an increase of 7% over the previous fiscal quarter, and a decrease of 4%, compared to 54% in the same quarter of last fiscal year. The Company continues to generate positive Adjusted EBITDA of $2,223,919 during the second quarter of fiscal 2026. (1) See "Non-IFRS financial measures" section below for reconciliation of EBITDA and Adjusted EBITDA.

The interest we received exceeded the amount ultimately raised, but we strategically chose to close on a smaller, more disciplined transaction. This allows us to advance our plans with a strong and supportive shareholder base while minimizing dilution and maintaining flexibility. The Offering was initially targeted at approximately $4 million; however, following discussions with the Lead Agent and strong investor interest, the Company determined it was in the best interest of shareholders to complete a $2 million financing. This strategic decision allowed the Company to focus on attracting a core group of high-quality, long-term investors who align with its vision and growth plans. "We are very pleased with the outcome of this successful financing," said Mike Perron, Chief Executive Officer of the Company. "The interest we received exceeded the amount ultimately raised, but we strategically chose to close on a smaller, more disciplined transaction. This allows us to advance our plans with a strong and supportive shareholder base while minimizing dilution and maintaining flexibility." The Company intends to use the net proceeds from the Offering for capital expenditures and brand-awareness initiatives and marketing activities. In connection with the Offering, the Company paid a cash commission of $143,233.95 and issued 220,360 broker warrants (the " Broker Warrants ") and a corporate finance fee paid through the issuance of 157,400 Units. Each Broker Warrant entitles the holder to acquire a Unit at the Issue Price for a period of three years from the Closing Date. Certain insiders of the Company participated in the Offering, acquiring an aggregate of 154,000 Units on the same basis as other subscribers. The participation in the Offering by insiders of the Company constitutes a "related party transaction" as such term is defined under Multilateral Instrument 61-101, Protection of Minority Security Holders in Special Transactions (" MI 61-101 "). The Company is relying on exemptions in MI 61-101 from the formal valuation and minority shareholder approval requirements of MI 61-101 as neither the fair market value of the Units subscribed for by the insiders, nor the consideration for the units paid by such insiders, is more than 25% of the Company's market capitalization. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to "U.S. persons" (as that term is defined in Rule 902(k) of Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
WE GROW
WITH PURPOSE
Our mission is to raise the standard for cannabis worldwide. Guided by passion, credibility, and an unwavering commitment to quality, we cultivate more than cannabis — we cultivate trust. Every product we grow and every partnership we build strengthens our community of consumers, patients, employees, and investors.
OUR BRANDS
We are proud to steward a growing portfolio of award-winning cannabis brands designed to meet diverse consumer needs.







